Jean-Michel Foidart

7PUBLICATIONS
17CO-AUTHORS
Toxicology (incl. clinical toxicology)Health and ecological risk assessmentEpidemiological modellingBioavailability and ecotoxicologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 27, 2025
Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61.

Jonathan Douxfils, Jean-Michel Foidart

|Aug 29, 2025
Body-identical estrogens in combined hormonal contraceptives: A safer path forward.

Nathalie Chabbert-Buffet, Ivonne J Diaz Yamal, Jonathan Douxfils

|Jun 28, 2023
Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study.

Jean Michel Foidart, Krzysztof Simon, Wulf H Utian

|Jun 10, 2023
Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment.

Anne Gallez, Gwenaël Nys, Vincent Wuidar

|Nov 18, 2022
Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women.

J Douxfils, U Gaspard, M Taziaux

|Aug 12, 2022
Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview.

David F Archer, Diana Mansour, Jean-Michel Foidart

Pageof 2

Frequent Collaborators

5 joint publications

Jonathan Douxfils

2 joint publications

Kristina Gemzell-Danielsson

2 joint publications

Nathalie Chabbert-Buffet

1 joint publications

Angelo Cagnacci